{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:23:33Z","timestamp":1791069813468,"version":"4.1.0"},"reference-count":32,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,1,31]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>PA28g acts as a co-repressor of HTLV-1 p30 to suppress virus replication and is required for the maintenance of viral latency. HTLV-1 has evolved a unique function mediated by its posttranscriptional repressor p30, which is not found in HTLV-2.<\/jats:p>","DOI":"10.1182\/blood-2012-03-420414","type":"journal-article","created":{"date-parts":[[2012,10,27]],"date-time":"2012-10-27T05:01:19Z","timestamp":1351314079000},"page":"791-800","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":20,"title":["PA28\u03b3 is a novel corepressor of HTLV-1 replication and controls viral latency"],"prefix":"10.1182","volume":"121","author":[{"given":"Nga Ling","family":"Ko","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Center for Viral Oncology, University of Kansas Medical Center, Kansas City, KS; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Center for Viral Oncology, University of Kansas Medical Center, Kansas City, KS; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia","family":"Bellon","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Center for Viral Oncology, University of Kansas Medical Center, Kansas City, KS; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue Tao","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Center for Viral Oncology, University of Kansas Medical Center, Kansas City, KS; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey P.","family":"Shevtsov","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, Rosalind Franklin University of Medicine and Science, North Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Dundr","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, Rosalind Franklin University of Medicine and Science, North Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Nicot","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Center for Viral Oncology, University of Kansas Medical Center, Kansas City, KS; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"10","key":"2019111817152858400_B1","doi-asserted-by":"crossref","first-page":"961","DOI":"10.4161\/cbt.10.10.13923","article-title":"Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention.","volume":"10","author":"Saha","year":"2010","journal-title":"Cancer Biol Ther"},{"issue":"12","key":"2019111817152858400_B2","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc Nat Acad Sci U S A"},{"issue":"8","key":"2019111817152858400_B3","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1073\/pnas.81.8.2534","article-title":"Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease.","volume":"81","author":"Yoshida","year":"1984","journal-title":"Proc Nat Acad Sci U S A"},{"issue":"6","key":"2019111817152858400_B4","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","article-title":"Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.","volume":"79","author":"Yoshida","year":"1982","journal-title":"Proc Nat Acad Sci U S A"},{"issue":"4","key":"2019111817152858400_B5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrc2111","article-title":"Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation.","volume":"7","author":"Matsuoka","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"2019111817152858400_B6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/jnci\/93.5.367","article-title":"Somatic mutation in human T-cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo.","volume":"93","author":"Mortreux","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"2019111817152858400_B7","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1128\/JVI.69.5.2863-2868.1995","article-title":"Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy.","volume":"69","author":"Wattel","year":"1995","journal-title":"J Virol"},{"issue":"11","key":"2019111817152858400_B8","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1182\/blood-2010-10-312926","article-title":"The host genomic environment of the provirus determines the abundance of HTLV-1\u2013infected T-cell clones.","volume":"117","author":"Gillet","year":"2011","journal-title":"Blood"},{"issue":"2","key":"2019111817152858400_B9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nm984","article-title":"HTLV-1\u2013encoded p30II is a post-transcriptional negative regulator of viral replication.","volume":"10","author":"Nicot","year":"2004","journal-title":"Nat Med"},{"issue":"2","key":"2019111817152858400_B10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.virol.2010.11.019","article-title":"The HTLV-1 hbz antisense gene indirectly promotes tax expression via down-regulation of p30(II) mRNA.","volume":"410","author":"Choudhary","year":"2011","journal-title":"Virology"},{"issue":"19","key":"2019111817152858400_B11","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1182\/blood-2010-05-284141","article-title":"Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits.","volume":"116","author":"Valeri","year":"2010","journal-title":"Blood"},{"issue":"10","key":"2019111817152858400_B12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrm2255","article-title":"Exporting RNA from the nucleus to the cytoplasm.","volume":"8","author":"Kohler","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"2019111817152858400_B13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1083\/jcb.200604099","article-title":"UV-induced fragmentation of Cajal bodies.","volume":"175","author":"Cioce","year":"2006","journal-title":"J Cell Biol"},{"issue":"38","key":"2019111817152858400_B14","doi-asserted-by":"crossref","first-page":"16619","DOI":"10.1073\/pnas.1010722107","article-title":"Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia.","volume":"107","author":"Pancewicz","year":"2010","journal-title":"Proc Nat Acad Sci U S A"},{"issue":"2","key":"2019111817152858400_B15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.abb.2004.03.021","article-title":"Purification procedures determine the proteasome activation properties of REG gamma (PA28 gamma).","volume":"425","author":"Gao","year":"2004","journal-title":"Arch Biochem Biophys"},{"issue":"19","key":"2019111817152858400_B16","doi-asserted-by":"crossref","first-page":"14608","DOI":"10.1074\/jbc.M611219200","article-title":"Human T-cell lymphotrophic virus type I rex and p30 interactions govern the switch between virus latency and replication.","volume":"282","author":"Sinha-Datta","year":"2007","journal-title":"J Biol Chem"},{"issue":"6660","key":"2019111817152858400_B17","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/37670","article-title":"Structure of the proteasome activator REGalpha (PA28alpha).","volume":"390","author":"Knowlton","year":"1997","journal-title":"Nature"},{"issue":"6","key":"2019111817152858400_B18","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1073\/pnas.95.6.2807","article-title":"Identification of an activation region in the proteasome activator REGalpha.","volume":"95","author":"Zhang","year":"1998","journal-title":"Proc Nat Acad Sci U S A"},{"issue":"3-4","key":"2019111817152858400_B19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0300-9084(01)01236-6","article-title":"Molecular dissection of the 11S REG (PA28) proteasome activators.","volume":"83","author":"Li","year":"2001","journal-title":"Biochimie"},{"issue":"6","key":"2019111817152858400_B20","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.4049\/jimmunol.172.6.3948","article-title":"Immune defects in 28-kDa proteasome activator gamma-deficient mice.","volume":"172","author":"Barton","year":"2004","journal-title":"J Immunol"},{"issue":"20","key":"2019111817152858400_B21","doi-asserted-by":"crossref","first-page":"11077","DOI":"10.1128\/JVI.78.20.11077-11083.2004","article-title":"Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator.","volume":"78","author":"Younis","year":"2004","journal-title":"J Virol"},{"issue":"3","key":"2019111817152858400_B22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0168-1702(93)90099-9","article-title":"Establishment of HTLV-1-infected cell lines from French, Guianese and West Indian patients and isolation of a proviral clone producing viral particles.","volume":"30","author":"Nicot","year":"1993","journal-title":"Virus Res"},{"issue":"2","key":"2019111817152858400_B23","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1006\/viro.1994.1581","article-title":"Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones.","volume":"204","author":"Kimata","year":"1994","journal-title":"Virology"},{"issue":"3","key":"2019111817152858400_B24","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1128\/JVI.69.3.1907-1912.1995","article-title":"Virions released from cells transfected with a molecular clone of human T-cell leukemia virus type I give rise to primary and secondary infections of T cells.","volume":"69","author":"Derse","year":"1995","journal-title":"J Virol"},{"issue":"6","key":"2019111817152858400_B25","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.177.6.1567","article-title":"High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease.","volume":"177","author":"Elovaara","year":"1993","journal-title":"J Exp Med"},{"key":"2019111817152858400_B26","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1038\/onc.2009.351","article-title":"Human tumor-associated viruses and new insights into the molecular mechanisms of cancer.","volume":"27","author":"Martin","year":"2008","journal-title":"Oncogene"},{"key":"2019111817152858400_B27","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1146\/annurev.immunol.18.1.665","article-title":"Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.","volume":"18","author":"Pierson","year":"2000","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"2019111817152858400_B28","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.1074\/jbc.M110.176354","article-title":"Human T-lymphotropic virus type 1 p30 interacts with REGgamma and modulates ATM (ataxia telangiectasia mutated) to promote cell survival.","volume":"286","author":"Anupam","year":"2011","journal-title":"J Biol Chem"},{"issue":"22","key":"2019111817152858400_B29","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1182\/blood-2010-08-304600","article-title":"Human T-lymphotropic type 1 virus p30 inhibits homologous recombination and favors unfaithful DNA repair.","volume":"117","author":"Baydoun","year":"2011","journal-title":"Blood"},{"key":"2019111817152858400_B30","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/1476-4598-9-302","article-title":"HTLV-1 p30 inhibits multiple S phase entry checkpoints, decreases cyclin E-CDK2 interactions and delays cell cycle progression.","volume":"9","author":"Baydoun","year":"2010","journal-title":"Mol Cancer"},{"issue":"19","key":"2019111817152858400_B31","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1182\/blood-2010-02-270751","article-title":"Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors.","volume":"116","author":"Afonso","year":"2010","journal-title":"Blood"},{"issue":"6","key":"2019111817152858400_B32","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/emboj.2008.25","article-title":"Proteasome activator PA28 gamma regulates p53 by enhancing its MDM2-mediated degradation.","volume":"27","author":"Zhang","year":"2008","journal-title":"EMBO J"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/5\/791\/1369877\/zh800513000791.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/5\/791\/1369877\/zh800513000791.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T06:03:00Z","timestamp":1594792980000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/121\/5\/791\/31398\/PA28%CE%B3-is-a-novel-corepressor-of-HTLV1-replication"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,31]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,1,31]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-03-420414","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,31]]}}}